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Pork products are a substantial source of human yer-
siniosis, a foodborne disease caused by Yersinia enteroco-
litica. Thus, the ability to eliminate this agent from pig herds 
would be an important step in producing human pathogen–
free pork. Pig herds free from Y. enterocolitica O:3/biovar 
4 have been established and maintained. According to se-
rologic and cultural testing results, 15 of 16 speciﬁ  c patho-
gen–free herds were free from Y. enterocolitica O:3/biovar 
4; this closed breeding pyramid has remained free from this 
organism since 1996. Pig herds free from human patho-
genic Y. enterocolitica suggest that human pathogen–free 
herds could be attained to provide pork free from zoonotic 
agents.
Y
ersinia enterocolitica is a major cause of foodborne 
disease in the industrialized world (1,2). The emer-
gence of Y. enterocolitica O:3 and O:9 in Europe and Japan 
in the 1970s and in North America by the end of the 1980s 
has been characterized as an example of a global pandem-
ic (3). Outbreaks of Y. enterocolitica O:3 have occurred 
among black US infants due to cross-contamination during 
household preparation of raw pork intestines (chitterlings) 
(4,5), and the main reservoir for Y. enterocolitica O:3 in 
Europe is the domestic pig population (6). A case–con-
trol study conducted by the US Centers for Disease Con-
trol and Prevention (CDC) and the Norwegian Institute of 
Public Health (NIPH) indicated pork products as a major 
source of yersiniosis in humans in Norway (7). As a result 
of this and other epidemiologic studies (6,8–10), improved 
slaughtering and dressing procedures of pigs (11,12) were 
implemented in Norwegian abattoirs in 1994. The decline 
in the incidence of human yersiniosis (13), which started in 
1995, is most likely the result of these preventive measures. 
Among the Nordic countries, Denmark, Norway, and Swe-
den started to improve slaughter hygiene by implement-
ing the plastic bag technique during 1990–1995; however, 
Finland did not implement this technique, which may have 
contributed to the higher level of human yersiniosis in this 
country than in the other Nordic countries (14).
During an outbreak in January and February 2006, 11 
human cases of Y. enterocolitica O:9/biovar 2 infection 
were identiﬁ  ed in Norway; 2 patients died and reactive ar-
thritis developed in 1 (15). A case–control study and micro-
biologic ﬁ  ndings indicated a processed pork product (jule-
sylte; Christmas brawn) as the probable source. Another, 
smaller, family outbreak of yersiniosis occurred, caused by 
Y. enterocolitica O:3/biovar 4 in brawn and was registered 
in the outbreak database at NIPH in 2006 (16).
Most Norwegian pig production is organized in a 
closed breeding system in which primary nucleus-herd 
farms sell breeding animals to secondary multiplying-herd 
farms. These multiplying-herd farms sell breeding animals 
to conventional-herd farms (farrowing to ﬁ  nishing herds or 
young pig production). In turn, animals from young pig–
production farms are sold to fattening-herd farms. These 
breeding pyramids are kept free from animal diseases such 
as sarcoptic mange, swine dysentery, and enzootic pneu-
monia. If successful elimination of human pathogenic Y. 
enterocolitica could be accomplished on the top levels of 
the breeding pyramids, prevalence of human pathogenic Y. 
enterocolitica might be lowered in the general pig popula-
tion. Previously, Skjerve et al. (17) indicated that interven-
tion at herd level is a possible strategy for maintenance of 
Y. enterocolitica O:3/biovar 4–free pig herds in Norway. 
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Serologic analysis showed 182 (63.4%) of 287 herds to be 
positive for Y. enterocolitica O:3. Among the seropositive 
herds in this study, signiﬁ  cantly fewer were mixed herds of 
piglets and fatteners (53.1%) than fattening herds (86%). 
Mixed herds represent a signiﬁ  cant protective factor against 
infection with Y. enterocolitica O:3/biovar 4 because the 
herd is not supplemented by animals brought in from out-
side sources. Thus, reducing the herd prevalence of Y. en-
terocolitica O:3/biovar 4 may be possible by minimizing 
contact between infected and noninfected herds.
The ability to create pig herds free of human patho-
genic Y. enterocolitica has been evaluated. We report that a 
speciﬁ  c pathogen–free (SPF) breeding pyramid with focus 
on animal disease can be established and maintained free 
from Y. enterocolitica O:3/biovar 4.
Material and Methods
Herds
In 1996, the ﬁ  rst SPF nucleus herd (herd 1; 100 breed-
ing sows) was established by hysterectomy, and the pig-
lets were reared without contact with other pigs. In 1999, 
a second nucleus SPF herd (herd 2; 65 breeding sows) 
was established with gilts from herd 1. These 2 herds have 
been totally isolated from other herds, except for artiﬁ  cial 
insemination. Since 1997, 14 new SPF herds have been es-
tablished with gilts from 1 or both of the above-mentioned 
SPF nucleus herds; each has been maintained as a closed 
herd (or supplemented with replacement gilts from 1 of the 
2 SPF nucleus herds). Each of these 14 new SPF herds had 
an average of 60 animals (range 20–150). All SPF herds 
are housed, the water supply is potable, and pest control 
systems are established. Pets and wild animals cannot en-
ter the pig house. The owner, herdsmen, veterinarians, and 
technicians must shower and change clothes before enter-
ing the pig housing. Many pig herds organized in the gen-
eral closed breeding system have also implemented many 
of these preventive measures.
Testing of Pigs
Previously, Nesbakken et al. (18) have shown that Y. 
enterocolitica O:3/biovar 4 can be detected in different age 
groups of pigs by 1) serologic testing of pigs at all ages 
from ≈100 days, including at slaughter when the pigs are 
150–180 days old; and 2) bacteriologic examination of fe-
ces from pigs of all ages from 85 days until ≈135 days. In 
most instances, the testing of pigs in our study has been in 
accordance with the conclusions of Nesbakken et al (18). 
Collection of Blood Samples
After the original 54 samples were tested in 1996, 
blood samples from 30–60 pigs in herd 1 were tested for 
antibodies against Y. enterocolitica O:3 every year from 
1998 through 2007, and samples from 30 pigs in herd 2 
were tested each year from 2001 through 2006. Periodi-
cally, from 2002 through 2007, blood samples from 19–60 
pigs from the 14 secondary SPF herds were tested (Table). 
Most blood samples were collected from 4- to 6-month-old 
fatteners or gilts. Through 2001, some samples from pigs in 
the 2 nucleus herds were from sows. In total, blood samples 
from 1,083 pigs from 16 different herds were tested for an-
tibodies against Y. enterocolitica O:3.
Collection of Fecal Samples
Each herd was sampled once. In total, 286 samples 
were collected from 18–24 animals from each of 4 herds in 
2005 and 10 herds in 2006 (Table). Fecal samples were not 
collected from herds 5 (the owner did not give permission) 
and 9 (no longer registered as an SPF herd since 2006). Fe-
cal samples weighed 0.1–36.8 g. The average amounts per 
herd tested varied from an average of 0.8 g (range 0.1–3.3 
g) to an average of 23 g (range 8–31 g). The fecal samples 
were aseptically collected from the rectum of the pigs (86–
150 days of age) by use of a clean plastic glove.
Serologic Methods
Serum samples were analyzed for antibodies against Y. 
enterocolitica O:3 by using an indirect pig immunoglobu-
lin lipopolysaccharide ELISA (19) at the Danish Veterinary 
Institute, Technical University of Denmark, Copenhagen. 
A basic cut-off of optical density (OD) 20% was used to 
maximize the speciﬁ  city of the ELISA.
Isolation and Characterization of Y. enterocolitica
Y. enterocolitica were cultured and isolated according 
to the International Organization for Standardization (20) 
with modiﬁ  cations (21,22). Colonies characteristic for Yer-
sinia were conﬁ  rmed biochemically, ﬁ  rst by selecting only 
lactose-negative, urease-positive colonies and later with 
Vitek (BioMerieux Limited, Marcy l’Etoile, France) by us-
ing the revised biogrouping scheme for Y. enterocolitica 
(23) as a key, and serologically for O:3 and O:9 reactivity 
(63501 and 63502; Sanoﬁ   Diagnostics-Pasteur, Marnes la 
Coquette, France).
Results and Discussion
The serologic and the bacteriologic results showed a 
low rate of exposure to Y. enterocolitica O:3/biovar 4 in the 
pigs from the closed SPF herds (Table). During the ﬁ  rst 5 
years, 10 of 174 blood samples from pigs in herd 1 had low 
levels of antibodies against Y. enterocolitica O:3; however, 
because some of these pigs were old sows, the low titers 
(OD >20% but <31%) are consistent with past exposure 
to the organism or nonspeciﬁ  c cross-reaction rather than 
active infection. Bowman et al. (24) report that gestating 
sows had the second highest prevalence of human patho-
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genic Y. enterocolitica among the different age categories 
at herd level; Y. enterocolitica was never detected in the 
farrowing sows. Gürtler et al. (25) did not detect human 
pathogenic Y. enterocolitica among sows. However, ac-
cording to these 2 reports, the sows were investigated by 
culture and not by serologic testing (24,25). In the past 5 
years (2002–2007), none of the 223 blood samples taken 
from pigs in this herd has been positive for Y. enteroco-
litica. Although some of the blood samples from the 2 
nucleus herds were from old sows, most were from fat-
tening pigs at slaughter. If nucleus herd 1 had been truly 
positive, pigs purchased from this herd would probably 
have infected the other herds because this herd was at the 
top of the breeding pyramid. In herds 3 and 10, 1 of 61 an-
imals was positive. When a herd has a history of infection 
with Y. enterocolitica O:3/biovar 4, antibodies are widely 
distributed among the animals (17,18). Accordingly, it is 
not likely that herds 1, 3, and 10 were infected by Y. en-
terocolitica O:3/biovar 4. The speciﬁ  city of the serologic 
ELISA used is not fully known; false positives might ap-
pear. Only 1 of the 16 herds examined (herd 14) was clas-
siﬁ  ed as serologically positive for antibodies against Y. 
enterocolitica O:3. Among the 30 animals tested, 15 were 
positive (OD average 39%; range 0%–109%). This herd 
was also the only one that was positive for Y. enterocolit-
ica O:3/biovar 4 according to culture result. The isolation 
method used in our study has proven to be sensitive for 
isolation of Y. enterocolitica O:3/biovar 4 even when the 
fecal samples are small (18,21). On the basis of intestinal 
tract content samples (n = 120), there was no statistical 
difference between the isolation method used in our study 
and the BUGS’n BEADS (Genpoint, Oslo, Norway) de-
tection method (PCR) for virulent Y. enterocolitica (21).
According to serologic testing results, 15 of the 16 SPF 
herds examined were free from Y. enterocolitica O:3/bi-
ovar 4. The ﬁ  rst basic nucleus herd at the top of this breed-
ing pyramid has remained free from this pathogenic variant 
since the herd’s establishment in 1996. A total of 13 herds 
were conﬁ  rmed negative for Y. enterocolitica O:3/biovar 4 
by culture of feces. Broadly, these ﬁ  ndings show that clus-
ters of pig herds free from Y. enterocolitica O:3/biovar 4 
can be established and kept free from this human patho-
genic variant for many years. Christensen (26) also docu-
mented a low level of human pathogenic Y. enterocolitica 
in 4 SPF herds examined by tonsil swabs in Denmark dur-
ing 1978–1979. From 99 pigs he found only 1 isolate of Y. 
enterocolitica serovar O:3/biovar 4.
The low prevalence of human pathogenic Y. enteroco-
litica observed in the herds’ immediate environment (e.g., 
water, rodents, ﬂ  ies) by Pilon et al. (27) suggests that the 
environment does not represent the main source of con-
tamination of pigs by human pathogenic Y. enterocolitica. 
Rather, transmission is more likely from other infected 
pigs. Thus, mixed herds in closed health and breeding pyra-
mids represent an important barrier against infection with 
Y. enterocolitica O:3/biovar 4. Reduction in prevalence of 
human pathogenic Y. enterocolitica at the top levels of the 
health and breeding pyramids may also reduce the preva-
lence of Y. enterocolitica O:3/biovar 4 in the general pig 
population. The meat industry could then categorize herds 
by serologic or bacteriologic methods and use these results 
in its strategy to reduce the risks for consumers. Serologic 
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Table. Antibodies against Yersinia enterocolitica O:3 in blood samples and culture of feces from pigs in a closed system of 16 SPF 
herds in Norway* 
Herd no. (year established)  Serologic testing (1996–2007), no. pos/no. tested  Culture (2005–2006), no. pos./no. tested 
1 (1996)  10/397† 0/20
2 (1999)  0/150 0/20
3 (1997)  1/61 0/21
4 (1997)  0/19 0/20
5 (1998)  0/30 NA‡
6 (1999)  0/34 0/20
7 (1999)  0/20 0/20
8 (2000)  0/60 0/20
9 (2001)  0/30 NA‡
10 (2002)  1/61 0/20
11 (2002)  0/20 0/20
12 (2003)  0/30 0/22
13 (2003)  0/51 0/18
14 (2004)  15/30 11/24§
15 (2004)  0/50 0/23
16 (2004)  0/30 0/20
*SPF, specific pathogen–free. Herds 1 and 2 are nucleus herds. Herds 3–16 were established with gilts from 1 or both of the nucleus herds. A basic cut-
off of optical density of 20% was used to maximize the specificity of the ELISA. 
†During the first 5 years, 10 of 174 blood samples from pigs in herd 1 had a low level of antibodies against Y. enterocolitica O:3 (OD >20 but <31). None 
of the 223 blood samples taken from pigs in this herd from 2002 through 2007 was positive. The low-positive reactions from pigs in herd 1 might have 
been the result of nonspecific reactions because a few of these samples were from old sows, which might have more serologic interference. 
‡NA, not applicable; no culture of feces. 
§Positive for Y. enterocolitica O:3/biovar 4. Pig Herds Free from Yersinia enterocolitica
testing is preferable to bacteriologic methods on the basis 
of practicality, time-saving aspects, and costs. If human 
pathogenic Y. enterocolitica–free segments of the pig pop-
ulation could be established, preharvest risk management 
might be possible by using serologic methods to categorize 
herds. If this experience is used in the general health and 
breeding pyramids of pig herds, the Norwegian meat indus-
try could provide pork from pigs raised in herds free from 
human pathogenic Y. enterocolitica, which might be the 
starting point for providing human pathogen–free (HPF) 
pork on the market. The following facts should be consid-
ered in discussions of the possibility of establishing HPF 
herds: 1) <0.1% of the pigs in Norway harbor Salmonella 
(28); 2) the most recent case of Trichinella infection in pigs 
was in 1994 (28); 3) 2.6% of 1,605 pigs from 321 herds had 
antibodies against Toxoplasma gondii (29), and only 1.3% 
of the mixed herds had antibodies against T. gondii accord-
ing to the data on which this article is based; and 4) ≈100% 
of the pigs harbor Campylobacter spp. (21).
Closed SPF pig herds are probably nearly free from 
Salmonella, Trichinella, T. gondii, and, according to our 
ﬁ  ndings, even human pathogenic Y. enterocolitica. Free-
dom from Campylobacter spp. in pigs is probably impos-
sible. However, blast chilling after the slaughtering process 
seems to reduce the number of Campylobacter spp. ≈100% 
(30; Nesbakken et al., unpub. data). Thus, in the future, 
pork from Norwegian SPF pig herds and even mixed herds 
in closed breeding pyramids might be marketed as HPF. 
Another aspect to consider is the environment. Usually 
manure from pig farms is spread in ﬁ  elds and may contami-
nate wild animals, lakes, and rivers. Drinking water may 
thereby be contaminated with pathogenic Y. enterocolitica. 
This contamination has a human health aspect because one 
of the risk factors for human yersiniosis might be drinking 
water that has not been disinfected (7). Thus, in addition to 
their public health beneﬁ  ts, human pathogenic Y. entero-
colitica–free herds might have a positive environmental 
effect.
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